
AstraZeneca Korea, Oncosoft team up to enhance NF1 treatment with AI
AstraZeneca Korea said Friday that it has signed a memorandum of understanding (MOU) with AI-based software startup Oncosoft to enhance the diagnosis and assessment of the rare disease neurofibromatosis type 1 (NF1). The agreement seeks to expand treatment …